SHANGHAI – When Johnson & Johnson (J&J) set up its network of five Innovation Centers in the world's life science hot spots – Boston, California, London and Shanghai – it put into action a global experiment: Could a giant find a way to systematically engage in early stage possibilities in drugs, devices or consumer health with its innovative, entrepreneurial brethren? Having just announced 17 deals across the globe bringing the overall deal total to 200, they have shown if they fail, it won't be for lack of effort.